{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:07:39Z","timestamp":1791439659873,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bjaed.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Education"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bjae.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:59:34Z","timestamp":1766181574000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Migraine part 2: evidence-based acute and preventive treatment"],"prefix":"10.1016","volume":"26","author":[{"given":"R.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zienius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjae.2025.11.003_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"Stovner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bjae.2025.11.003_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1478271520063603003","article-title":"Acute neurology in a twenty-first century district general hospital","volume":"36","author":"Weatherall","year":"2006","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.bjae.2025.11.003_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bjae.2025.07.004","article-title":"Migraine: types symptoms, pathophysiology and diagnosis","volume":"25","author":"Dorsey","year":"2025","journal-title":"BJA Ed"},{"key":"10.1016\/j.bjae.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1001\/jama.284.20.2599","article-title":"Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial","volume":"284","author":"Lipton","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.bjae.2025.11.003_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/head.12550","article-title":"Acute migraine treatment in adults","volume":"55","author":"Becker","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib7","first-page":"Cd009108","article-title":"Sumatriptan (all routes of administration) for acute migraine attacks in adults \u2013 overview of Cochrane reviews","volume":"2014","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjae.2025.11.003_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-2982.2005.01010.x","article-title":"Infrequent or non-response to oral sumatriptan does not predict response to other triptans\u2014review of four trials","volume":"26","author":"Dahlof","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080107","article-title":"Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis","volume":"386","author":"Karlsson","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bjae.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs","volume":"59","author":"Limmroth","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bjae.2025.11.003_bib11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(07)70272-7","article-title":"Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Diener","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bjae.2025.11.003_bib12","unstructured":"National Institute for Health and Care Excellence. Headaches in over 12s: diagnosis and management. Clinical guideline (CG150). Available from: www.nice.org.uk\/guidance\/CG150 (accessed 20 August 2024)."},{"key":"10.1016\/j.bjae.2025.11.003_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00048677909159160","article-title":"A double-blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression","volume":"13","author":"Kiloh","year":"1979","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.bjae.2025.11.003_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study","volume":"34","author":"Stovner","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10194-019-0976-1","article-title":"An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study","volume":"20","author":"Ahmed","year":"2019","journal-title":"J Headache Pain"},{"key":"10.1016\/j.bjae.2025.11.003_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/03331024251327387","article-title":"OnabotulinumtoxinA treatment for chronic migraine in pregnancy: an updated report of real-world headache and pregnancy outcome over 14 years in Hull","volume":"45","author":"Wong","year":"2025","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(00)00232-3","article-title":"Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks","volume":"86","author":"Ashina","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.bjae.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clineuro.2017.12.026","article-title":"The efficacy of greater occipital nerve block for the treatment of migraine: a systematic review and meta-analysis","volume":"165","author":"Zhang","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.bjae.2025.11.003_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/practneurol-2020-002612","article-title":"Peripheral nerve blocks for headache disorders","volume":"21","author":"Fernandes","year":"2021","journal-title":"Pract Neurol"},{"key":"10.1016\/j.bjae.2025.11.003_bib28","article-title":"Sphenopalatine ganglion block for the treatment of acute migraine headache","volume":"2018","author":"Binfalah","year":"2018","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.bjae.2025.11.003_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/head.12458","article-title":"A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(\u00ae) as acute treatment for chronic migraine","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and prophylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bjae.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjae.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","article-title":"Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial","volume":"9","author":"Lipton","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bjae.2025.11.003_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0333102418762525","article-title":"A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)","volume":"38","author":"Starling","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib36","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","article-title":"Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study","volume":"91","author":"Tassorelli","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.bjae.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000002918","article-title":"Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study","volume":"87","author":"Silberstein","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bjae.2025.11.003_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s10194-015-0542-4","article-title":"Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study","volume":"16","author":"Barbanti","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.bjae.2025.11.003_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/1129-2377-14-S1-P184","article-title":"Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly\u00ae device (PREMICE): a multi-centre, randomized, sham-controlled trial","volume":"14","author":"Schoenen","year":"2013","journal-title":"J Headache Pain"},{"key":"10.1016\/j.bjae.2025.11.003_bib40","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41598-022-09071-6","article-title":"Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)","volume":"12","author":"Kuruvilla","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjae.2025.11.003_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/head.14350","article-title":"Migraine treatment with external concurrent occipital and trigeminal neurostimulation \u2013 a randomised controlled trial","volume":"62","author":"Tepper","year":"2022","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/head.13551","article-title":"Remote electrical neuromodulation relieves acute migraine: a randomised, double-blind, placebo-controlled, multicenter trial","volume":"59","author":"Yarnitsky","year":"2019","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/head.14469","article-title":"Remote electrical neuromodulation for migraine prevention: a double-blind, randomised, placebo-controlled clinical trial","volume":"63","author":"Tepper","year":"2023","journal-title":"Headache"},{"key":"10.1016\/j.bjae.2025.11.003_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0333102410381142","article-title":"Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study","volume":"31","author":"Saper","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bjae.2025.11.003_bib45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0333102412462642","article-title":"Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study","volume":"32","author":"Silberstein","year":"2012","journal-title":"Cephalalgia"}],"container-title":["BJA Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2058534925001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2058534925001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:44:49Z","timestamp":1769024689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2058534925001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2058534925001040"],"URL":"https:\/\/doi.org\/10.1016\/j.bjae.2025.11.003","relation":{},"ISSN":["2058-5349"],"issn-type":[{"value":"2058-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migraine part 2: evidence-based acute and preventive treatment","name":"articletitle","label":"Article Title"},{"value":"BJA Education","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjae.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}